Ismail S, Funk MJ, Flythe JE. Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis. J Am Soc Nephrol 2024 May 20. doi: 10.1681/ASN.0000000000000386.
PMID: 38767970